Optimal management of oligometastatic prostate cancer: current state and future directions

20260 citationsJournal Article

Authors

Michael K. Rooney · Spanish Oncology Genitourinary Group

Paul G. Corn · The University of Texas MD Anderson Cancer Center

Phuoc T. Tran · Spanish Oncology Genitourinary Group

Abstract

The integration of MDT with modern systemic and biologically informed strategies holds promise for personalized management of oligoPCa. Future efforts should prioritize biomarker- driven patient selection and rational treatment sequencing to optimize long-term outcomes.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Radiopharmaceutical Chemistry and Applications

Publication Details

Published in: Current Opinion in Oncology

Volume 38, Issue 3, pp. 236-242

DOI: 10.1097/cco.0000000000001229

Field-Weighted Citation Impact: 0.00

Command Palette

Optimal management of oligometastatic prostate cancer: current state and future directions

Authors

Abstract

Topics & Keywords

Publication Details